Skip to main content

Table 4 STD Productivity Loss and Indirect Costs in Propensity Score Matched Cohorts with STD Eligibility

From: Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures

Measure

Patients with STD Eligibility

With CVERP

Without CVERP

p-value

N = 21,006

N = 21,006

 

n/mean

%/SD

n/mean

%/SD

 

During the 1st month of follow-up:

     

Patients reporting STD (n, %)

8,764

41.7

1,011

4.8

<.001

Monthly hours lost due to STD (mean, SD)

57.7

74.6

6.0

29.7

<.001

Indirect costs associated with STD (mean, SD)

$996

$1,309

$102

$506

<.001

Patients with ≥ 1 year of follow-up (n, %)

12,632

60.1

13,527

64.4

 

During the 1st year of follow-up:

     

Patients reporting STD (n, %)

5,890

46.6

1,406

10.4

<.001

Monthly hours lost due to STD (mean, SD)

16.3

30.8

3.6

16.7

<.001

Indirect costs associated with STD (mean, SD)

$281

$529

$60

$278

<.001

Patients with ≥ 2 years of follow-up (n, %)

7,196

34.3

8,038

38.3

 

During the 2nd year of follow-up:

     

Patients reporting STD (n, %)

1,031

14.3

734

9.1

<.001

Monthly hours lost due to STD (mean, SD)

4.7

18.0

2.7

13.3

<.001

Indirect costs associated with STD (mean, SD)

$79

$308

$45

$219

<.001

Patients with ≥ 3 years of follow-up (n, %)

3,984

19.0

4,635

22.1

 

During the 3rd year of follow-up:

     

Patients reporting STD (n, %)

536

13.5

364

7.9

<.001

Monthly hours lost due to STD (mean, SD)

4.4

17.9

2.1

10.8

<.001

Indirect costs associated with STD (mean, SD)

$73

$298

$34

$177

<.001

  1. CVERP: cardiovascular events and related clinical procedures; SD: standard deviation; STD: short-term disability